BioSpace News Archive

Deals

ClinicalMind Announces Acquisition Of IC Axon

ClinicalMind, LLC (CM), a premier and award-winning healthcare communications company, announced today that it has acquired IC Axon, a leader in developing science-driven training for pharmaceutical and life science companies.

September 25, 2020
·
2 min read
Pharm Country

Study Finds No Racial Disparity in COVID-19 Case Fatality Rates at Montefiore, When Controlling for Key Risk Factors

Research by Montefiore and Albert Einstein College of Medicine found that Black and Hispanic patients had a higher occurrence of pre-existing conditions and higher rates of hospitalization

September 25, 2020
·
5 min read
Drug Development

Galecto Raises $64 Million to Accelerate Development of Clinical PipelineFunds will support preparations for potential EU conditional approval of GB0139 in IPF and multiple new Phase 2 clinical trials

Galecto, Inc., a privately-held biotechnology company focused on the development of novel treatments for fibrosis and cancer, announced today the successful completion of a $64 million equity financing.

September 25, 2020
·
2 min read
Genetown

Blueprint Medicines Announces European Commission Approval of AYVAKYT® (avapritinib) for the Treatment of Adults with Unresectable or Metastatic PDGFRA D842V Mutant Gastrointestinal Stromal Tumors

-- First highly effective treatment option approved in Europe for PDGFRA D842V mutant GIST -- -- 95% ORR and 22.1 month median DOR in patients with unresectable or metastatic PDGFRA D842V mutant GIST in the NAVIGATOR trial1 --

September 25, 2020
·
10 min read
Policy

Recognizing the scientific impact of Dr. Frank Graham’s HEK 293 cell line

The National Research Council of Canada formally recognized the scientific impact of the HEK 293 cell line, originally created by Dr. Frank Graham nearly 50 years ago, and its importance in the production of biologic molecules, including current COVID-19 vaccine product candidates.

September 25, 2020
·
3 min read
The 510(k) clearance of accessories for the SixFix® Circular Fixation System improves versatility and ease-of-use

AMDT Holdings, Inc. develops disruptive products to address existing and emerging needs in the extremity market. The flagship products for AMDT Holdings are the patented SixFix® Circular Fixation System, the patented SixFix Deformity Analysis and Correction Software, and the patented AMDT Mini-Rail.

September 25, 2020
·
2 min read
RemeGen Announces US FDA Has Granted Breakthrough Therapy Designation for Disitamab Vedotin (RC48) in Urothelial Cancer

RemeGen Co., Ltd. (“RemeGen”) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation for disitamab vedotin (RC48), a novel h

September 25, 2020
·
4 min read
Policy

AHF Rings Alarm Over Nationwide Shortage of STD Test Kits

Recent CDC ‘Dear Colleagues’ letter warns of “… extreme shortages of STI test kits and laboratory supplies, most notably for chlamydia and gonorrhea” and offers considerations for prioritizing testing

September 25, 2020
·
3 min read
Binovi Congratulates the Dallas Stars on Their National Hockey League (NHL) Western Conference Championship

Binovi Technologies Corp., wishes to congratulate the National Hockey League’s Dallas Stars on their Western Conference Championship and berth in the Stanley Cup Finals.

September 25, 2020
·
3 min read
Vigil Health Solutions Announces Normal Course Issuer Bid

Vigil Health Solutions Inc. (“Vigil” or the “Company”) (TSX-VEN: VGL) announced today that the TSX Venture Exchange (the “Exchange”) has accepted a notice of intention to make a normal course issuer bid (the “Bid”).

September 25, 2020
·
5 min read